Kimberly Cockerham, MD

Brady Neuroscience Clinic
San Diego, California, United States

Disclosure information not submitted.

Presentation(s):

• ORF49-04 - Characterization of Proptosis Response in the THRIVE Phase 3 Trial of Veligrotug for Active Thyroid Eye Disease (TED)

  Monday, June 15, 2026
  2:00 PM - 2:15 PM CT